AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,366,350 | -17.6% | 91,091 | -15.3% | 0.19% | -9.5% |
| Q2 2023 | $7,727,321 | +15.7% | 107,533 | -0.7% | 0.21% | +8.8% |
| Q1 2023 | $6,678,772 | +89740.9% | 108,281 | +12.3% | 0.19% | -17.2% |
| Q4 2022 | $7,434 | -99.8% | 96,386 | -9.8% | 0.23% | +51.3% |
| Q3 2022 | $4,767,000 | -11.9% | 106,839 | -24.4% | 0.15% | -5.5% |
| Q2 2022 | $5,411,000 | -21.1% | 141,284 | -14.7% | 0.16% | +0.6% |
| Q1 2022 | $6,857,000 | +52.1% | 165,656 | +38.9% | 0.16% | +80.0% |
| Q4 2021 | $4,507,000 | +18.0% | 119,298 | +2.9% | 0.09% | +13.9% |
| Q3 2021 | $3,821,000 | -59.2% | 115,939 | -16.6% | 0.08% | -53.0% |
| Q2 2021 | $9,373,000 | +28.9% | 138,935 | +8.2% | 0.17% | +24.4% |
| Q1 2021 | $7,270,000 | -39.0% | 128,405 | -12.2% | 0.14% | -40.5% |
| Q4 2020 | $11,921,000 | – | 146,325 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |